• $1.4B
    Market Cap
  • 868.83%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
19.4M
+68.04%
11.5M
+642.47%
1.6M
-59.98%
3.9M
-87.58%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
19.4M
+68.04%
11.5M
+642.47%
1.6M
-59.98%
3.9M
-87.58%
Sales and Marketing Expense
0
-100.00%
36,000
-2.70%
37,000
+54.17%
24,000
+4.35%
Research and Development Expense
-22.8M
+28.09%
-17.8M
-24.37%
-23.5M
+85.63%
-12.7M
-37.78%
Depreciation and Amortization Expense
109,000
-53.22%
233,000
-31.87%
342,000
-39.15%
562,000
-36.14%
Total Operating Expenses
4.2M
-27.36%
5.7M
-22.03%
7.4M
-0.97%
7.4M
-11.90%
Operating Profit
-7.5M
-37.26%
-12.0M
-59.00%
-29.3M
+80.41%
-16.2M
-648.04%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-7.5M
-37.26%
-12.0M
-59.00%
-29.3M
+80.41%
-16.2M
-604.32%
Income Taxes
0
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-6.1M
-42.09%
-10.6M
-61.16%
-27.2M
+82.52%
-14.9M
-563.30%
Net Income from Continuing Operations Applicable to Common
-6.1M
-42.09%
-10.6M
-61.16%
-27.2M
+82.52%
-14.9M
-563.30%
Basic EPS and Net Income
-2.19
+476.32%
-0.38
-62.38%
-1.01
+55.38%
-0.65
-564.29%
Diluted EPS and Net Income
-2.19
+476.32%
-0.38
-62.38%
-1.01
+55.38%
-0.65
-564.29%
Basic Weighted Average Shares
2.8M
-90.00%
27.9M
+2.84%
27.1M
+17.11%
23.1M
+0.28%
Diluted Weighted Average Shares
2.8M
-90.00%
27.9M
+2.84%
27.1M
+17.11%
23.1M
-1.86%
Balance Sheet
Cash and Cash Equivalents
11.0M
-43.39%
19.5M
+159.40%
7.5M
-39.64%
12.4M
-38.02%
Short-Term Investments
13.0M
+193.02%
4.4M
-78.38%
20.5M
+135.90%
8.7M
+407.78%
Cash and Cash Equivalents and Short-Term Investments
24.0M
+0.36%
23.9M
-14.54%
28.0M
+32.46%
21.1M
-3.07%
Total Current Assets
27.0M
-13.82%
31.3M
-23.98%
41.2M
-4.39%
43.1M
-24.61%
Accumulated Depreciation
4.3M
-29.07%
6.0M
+3.79%
5.8M
+1.58%
5.7M
+10.91%
Property and Plant and Equipment and Net
140,000
-30.69%
202,000
-53.46%
434,000
-34.24%
660,000
-37.20%
Total Long-Term Assets
2.9M
-35.27%
4.6M
+10.46%
4.1M
+15.31%
3.6M
-70.43%
Total Assets
29.9M
-16.54%
35.8M
-20.85%
45.3M
-2.88%
46.6M
-32.61%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
6.2M
+16.76%
5.3M
+16.87%
4.5M
+35.84%
3.3M
-71.53%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
935,000
-45.35%
1.7M
-19.33%
2.1M
+95.30%
1.1M
-42.93%
Total Liabilities
7.1M
+1.57%
7.0M
+5.31%
6.6M
+50.46%
4.4M
-67.52%
Retained Earnings
-237.0M
+2.65%
-230.9M
+4.80%
-220.3M
+14.11%
-193.1M
+8.38%
Total Stockholders Equity
22.8M
-20.93%
28.9M
-25.34%
38.6M
-8.45%
42.2M
-24.07%
Total Shares Outstanding
2.8M
-90.00%
27.9M
0.00%
27.9M
+20.44%
23.1M
+0.01%
Cash Flow
Cash from Operating Activities
322,000
+102.32%
-13.9M
-21.66%
-17.7M
+86.95%
-9.5M
+23.31%
Capital Expenditures
47,000
+2,250.00%
2,000
-98.51%
134,000
-21.64%
171,000
+19.58%
Cash from Investing Activities
-8.6M
-132.14%
26.7M
+373.99%
-9.7M
-673.40%
1.7M
-91.45%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6,000
N/A
0
-100.00%
21.8M
+145,300.00%
15,000
-98.21%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-38.88%
-62.66%
-104.13%
-94.48%
-1,885.78%
+350.78%
-418.34%
-4,513.71%
Return on Assets
-18.63%
-28.55%
-26.08%
-56.00%
-59.27%
+129.99%
-25.77%
-613.44%
Return on Equity
-23.72%
-24.34%
-31.35%
-53.47%
-67.37%
+120.79%
-30.52%
-604.21%
Revenue Growth
68.04%
-89.41%
642.47%
+1,171.15%
-59.98%
-31.52%
-87.58%
-134.14%
Current Ratio
4.37
-26.19%
5.92
-34.96%
9.10
-29.61%
12.93
+164.79%
Cash Ratio
1.79
-51.52%
3.69
+121.96%
1.66
-55.57%
3.74
+117.68%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow